Methodology published · Market data, model notes, and corrections process are public · Data policy · Corrections policy

NASDAQ · Technology · Financials

Cerebras Systems financials & valuation

Reported statements, fiscal periods and valuation definitions in one place.

Section freshness

Prices as of Oct 2, 4:00 PM EDT · Fundamentals checked Oct 3, 5:07 PM EDT · Statement period ended Jun 30, 2026

Financial statements

Revenue

180.11M

Q2 · ended Jun 30, 2026

Operating Income

-477.23M

Q2 · ended Jun 30, 2026

Net Income

-450.53M

Q2 · ended Jun 30, 2026

Amounts in USD. B = billions · M = millions. Scroll horizontally for earlier periods.

Sources, units & calculation notes

SEC Companyfacts. Per-share figures are in USD/share; margins in %, debt/equity in ×. TTM sums four consecutive quarters; balance sheets remain period-end balances. A trailing-twelve-month EPS figure is not the sum of the quarterly EPS cells. Growth requires comparable positive values. EPS uses the provider’s reported share basis; a missing quarter says it is not on file, or shows a derived figure only when net income and a plausible share count are already on the page. Mixed filing split bases are not summed. EPS growth and trend lines require matching documented accounting and split bases. Tab through controls; use arrow keys inside the table.

CBRS quarterly income
Q2 FY2026Ended Jun 30, 2026EPS source · As reported in the cited filing; not normalized across filingsFiled Aug 12, 2026Source filing	Q1 FY2026Ended Mar 31, 2026EPS source · As reported in the cited filing; not normalized across filingsFiled Jun 24, 2026Source filing	Q2 FY2025Ended Jun 30, 2025EPS source · As reported in the cited filing; not normalized across filingsAs reported in the Aug 12, 2026 filingSource filing	Q1 FY2025Ended Mar 31, 2025EPS source · As reported in the cited filing; not normalized across filingsAs reported in the Jun 24, 2026 filingSource filing	1Y change	3Y annual growth	Trend
-$2.98US GAAP · diluted As reported in the cited filing; not normalized across filings	-$0.22US GAAP · diluted As reported in the cited filing; not normalized across filings	$1.91US GAAP · diluted As reported in the cited filing; not normalized across filings	-$0.46US GAAP · diluted As reported in the cited filing; not normalized across filings	—	—	—
180.11M	193.41M	103.32M	99.51M	74.3%	—
-450.53M	-14.01M	309.51M	-23.87M	—	—
25.56M	86.18M	32.1M	41.6M	-20.4%	—
-477.23M	-15.04M	-57.18M	-28.47M	—	—

Earnings quality · Jun 30, 2026

Net income: -450.53M
Free cash flow: -476.73M
Stock-based compensation: 377.01M
FCF / net income: —
Accrual gap / revenue: -216.9%
Cash conversion: Not meaningful with non-positive or missing earnings

Accrual gap = (net income − operating cash flow) / revenue. TECHi descriptive thresholds: strong ≥100%, moderate 75–100%, weak <75%. CapEx timing, working capital and industry structure affect the ratio; it is not an accounting audit.

Download quarterly financial dataset

Changes between reports

Q2 Jun 30, 2026 versus Q1 Mar 31, 2026

Reported periods shown above are compared directly; a missing intervening quarter is not inferred. Margin changes are in percentage points (pp).

Revenue: 180.11M↓ -6.9%; Previous: 193.41M · USD
Gross margin: 14.19%↓ -30.4 pp; Previous: 44.56%
Operating margin: -264.97%↓ -257.2 pp; Previous: -7.77%
Net margin: -250.14%↓ -242.9 pp; Previous: -7.24%
Cash: 6.74B↑ +292.9%; Previous: 1.72B · USD
Debt: 918.24M↓ -6.6%; Previous: 982.92M · USD
Inventory: 32.67M↓ -63.3%; Previous: 89.04M · USD
Capex: 416.9M↑ +215.9%; Previous: 131.97M · USD
Stock-based compensation: 377.01M↑ +3830.0%; Previous: 9.59M · USD

Reported-period comparison. Guidance and risk-factor changes require reading the filings.

Read the filings

Valuation & ratios

Multiples with negative or missing earnings are not meaningful. Annual free cash flow yield uses the latest fiscal year; provider forward multiples may use a different earnings horizon.

Valuation history and definitions

5Y median / percentile: Five-year observations unavailable
Forward EPS vs trailing EPS: —
PEG: —PEG is the forward P/E divided by the expected EPS growth rate in percent.

EPS growth proxy compares the available annual estimate (FY2026 period end 2026-12-31) with trailing EPS; it is not a multi-year consensus growth rate. Historical valuation uses dated observations, using price divided by the annual EPS estimate recorded that day. Legacy provider P/E observations with an unknown earnings basis are excluded. Available P/E observations: 0.

Why provider ratios differ · reconciliation

Forward P/E can use next fiscal year, current fiscal year or next-twelve-month earnings; trailing P/E can use GAAP or adjusted earnings and different closing prices. TECHi compares figures with the same earnings basis and reporting period. Different definitions are not averaged together.

Metric	Value / formula	Source and date
Trailing P/E	N/M · non-positive earnings	Not supplied
Trailing EPS	-4.66	Yahoo Finance · Oct 3, 2026, 5:07 PM EDT
Price ÷ annual EPS estimate	N/M · non-positive estimated EPS	TECHi calculation · FY2026 period end 2026-12-31

All data sources

Search the dated figures used for this view. Each entry identifies its units, reporting period and calculation status.

How to use this page

Use this to decide whether the business supports the valuation.

Best for Revenue quality, margins, cash conversion, debt, and filing cadence.

Weak when One-time items or old filings dominate the most recent reported figures.

Browse all companies and funds

Research tools

Market closed

Regular hours: 9:30 AM–4:00 PM America/New_York

Next open: 2026-10-05 · 9:30 AM America/New_York

Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.